Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
DNA
Ginkgo Bioworks Holdings Inc. DNA
$8.23
โ–ผ -1.38% 24H
5.57143.68281.78419.89558.002021-042022-082023-112025-032026-06

About

Ginkgo Bioworks Holdings Inc. is a biotechnology company that operates as a platform for cell programming, delivering flexible, end-to-end services to address challenges across diverse markets including food and agriculture, pharmaceuticals, industrial and specialty chemicals. It organizes its operations into two primaโ€ฆ

SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees485
TickerDNA

Statistics

Market Cap$479.0M
Revenue (TTM)$170.2M
Net Income-$312.8M
Net Margin-183.8%
EPS$-5.64
P/E-1.40
P/S3.40
P/B1.10
EV/EBITDA-2.10
ROE-56.0%
Dividend Yieldโ€”
Price$8.23

Data: Twelve Data ยท Revenue = mcap / P/S

Ginkgo Bioworks Holdings Inc. (DNA) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap